Therapeutic targeting of tumor angiogenesis with VEGF inhibitors results in demonstrable , but transitory efficacy in certain human tumors and mouse models of cancer , limited by unconventional forms of adaptive/evasive resistance .
O O O B-DiseaseOrPhenotypicFeature O O B-GeneOrGeneProduct O O O O O O O O O O B-OrganismTaxon B-DiseaseOrPhenotypicFeature O B-OrganismTaxon O O B-DiseaseOrPhenotypicFeature O O O O O O O O O